Approval · Notice of Compliance 9712 · 2008
SANTYL: Notice of Compliance 9712
Issued August 12, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9712
- Date
- August 12, 2008
- Company
- Healthpoint Canada UlcMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing site
- Therapeutic class
- Enzymatic debriding agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SANTYL | Not yet assigned | — |
Medicinal ingredients
- COLLAGENASE 250 UNIT per G